EP0161817A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Urogastrone
Assignee: Imperial Chemical Industries Ltd
•
Filing: 1985-04-16
•
Granted: —
•
Expires: 2005-04-16
Abstract
Abstract The pharmaceutical compositions for oral administration comprise human urogastrone or a urogastrone fragment as active ingredient and such an active ingredient may be used for the manufacture of a medicament for promoting healing of a damaged alimentary tract.
Inventors
- 👤 Harold Gregory
- 👤 Keith Graham Mccullagh
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-25 02:01
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1808; A61P; A61P1/00; A61P1/04
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
29 words
The use of human urogastrone or a urogastrone fragment for the manufacture of an orally administrable medicament for promoting the healing of a damaged alimentary tract of a mammal.
Claim 2
Dependent Claim
29 words
The use of human urogastrone or a urogastrone fragment for the manufacture of an orally administrable medicament for promoting the healing of a damaged alimentary tract of a mammal.
Claim 3
Dependent Claim
23 words
The use of human urogastrone or a urogastrone fragment as claimed in claim 1 wherein the medicament is for promoting gastrointestinal ulcer healing.
Claim 4
Dependent Claim
25 words
The use of human urogastrone or a urogastrone fragment as claimed in claim 2 wherein the medicament is for promoting the healing of duodenal ulcers.
Claim 5
Dependent Claim
27 words
The use of human urogastrone or a urogastrone fragment as claimed in any one of the preceding claims wherein the medicament is presented in dosage unit form.
Claim 6
Dependent Claim
30 words
The use of human urogastrone or a urogastrone fragment as claimed in claim 1 wherein each dosage unit contains from 0.01 to 10 mg. of urogastrone or a urogastrone fragment.
Claim 7
Dependent Claim
36 words
The use of human urogastrone or a urogastrone fragment as claimed in any one of the preceding claims wherein the medicament is presented in association with written or printed instructions for the use of the medicament.
Claim 8
Dependent Claim
25 words
A pharmaceutical composition for oral administration which comprises human urogastrone or a urogastrone fragment as active ingredient in association with a pharmaceutical carrier or excipient.
Claim 9
Dependent Claim
25 words
A pharmaceutical composition for oral administration which comprises human urogastrone or a urogastrone fragment as active ingredient in association with a pharmaceutical carrier or excipient.
Claim 10
Dependent Claim
11 words
A composition as claimed in claim 7 in dosage unit form.
Claim 11
Dependent Claim
24 words
A composition as claimed in claim 8 wherein each dosage unit contains from 0.01 to 10 mg. of human urogastrone or a urogastrone fragment.
Claim 12
Dependent Claim
19 words
A composition as claimed in any one of claims 7 to 9 which comprises human urogastrone as active ingredient.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.